Xiaoying Chen's Publications

About Xiaoying Chen's Publications

Senior Research Fellow, Brain Health Program
  • PhD,
  • BPharm,
  • BMgt
  • Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke

    Neurology Date published:
  • Associations of an Abnormal Physiological Score With Outcomes in Acute Intracerebral Hemorrhage

    Stroke Date published:
  • Location and outcome after acute ischaemic stroke: the ENCHANTED trial

    Date published:
  • Intensive versus guideline-recommended blood pressure reduction in acute lacunar stroke with intravenous thrombolysis therapy: The ENCHANTED trial

    European Journal of Neurology Date published:
  • Combined utility of blood glucose and white blood cell in predicting outcome after acute ischemic stroke: The ENCHANTED trial

    Clinical Neurology and Neurosurgery Date published:
  • ENCHANTED2: A TRIAL OF INTENSIVE BLOOD PRESSURE MANAGEMENT AFTER MECHANICAL THROMBECTOMY FOR ACUTE ISCHEMIC STROKE

    Date published:
  • Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial

    Journal of Neurology, Neurosurgery & Psychiatry Date published:
  • Prognostic value of acute CT in stroke thrombolysis

    Journal of Neurology, Neurosurgery & Psychiatry Date published:
  • Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome

    Stroke Date published:
  • Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm

    Cerebrovascular Diseases Date published:
  • Thrombolysis Outcomes in Acute Ischemic Stroke by Fluid-Attenuated Inversion Recovery Hyperintense Arteries

    Stroke Date published:
  • Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke

    Stroke Date published:
  • Asian versus NonAsian, Differences in Characteristics, Management & Outcomes in the Enchanted Trial

    Date published:
  • Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm

    International Journal of Stroke Date published:
  • Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

    The Lancet Date published:
  • Baseline brain imaging signs and outcomes in the ENCHANTED trial

    Date published: